E Kok

661 total citations
20 papers, 568 citations indexed

About

E Kok is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, E Kok has authored 20 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in E Kok's work include Drug Transport and Resistance Mechanisms (10 papers), Cholesterol and Lipid Metabolism (8 papers) and Metabolism and Genetic Disorders (6 papers). E Kok is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Cholesterol and Lipid Metabolism (8 papers) and Metabolism and Genetic Disorders (6 papers). E Kok collaborates with scholars based in United States, Netherlands and Canada. E Kok's co-authors include Norman B. Javitt, Karl E. Anderson, Shlomo Burstein, Skaidrite K. Krisans, Marcel Gut, Bertram I. Cohen, Raphael Pfeffer, Elliot R. Siegel, Lawrence M. Gartner and Kevin P. Morrissey and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The FASEB Journal.

In The Last Decade

E Kok

20 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Kok United States 12 346 285 215 91 88 20 568
F. W. Cheng United States 12 278 0.8× 258 0.9× 216 1.0× 95 1.0× 84 1.0× 14 547
H. J. Weis Germany 10 314 0.9× 228 0.8× 132 0.6× 63 0.7× 57 0.6× 21 585
H.J.M. Kempen Netherlands 13 327 0.9× 143 0.5× 270 1.3× 26 0.3× 63 0.7× 18 612
Santhirasegaram Balasubramaniam United Kingdom 7 328 0.9× 133 0.5× 191 0.9× 34 0.4× 64 0.7× 8 467
Reno Z. Vlahcevic United States 9 358 1.0× 429 1.5× 122 0.6× 30 0.3× 100 1.1× 9 671
Jan‐Erik Åkerlund Sweden 11 304 0.9× 176 0.6× 120 0.6× 28 0.3× 51 0.6× 12 432
M R Nemali United States 7 165 0.5× 131 0.5× 487 2.3× 116 1.3× 53 0.6× 9 677
Patricia von Dippe United States 16 196 0.6× 458 1.6× 284 1.3× 126 1.4× 213 2.4× 18 899
Leslie R. Schwarz Germany 11 99 0.3× 374 1.3× 149 0.7× 65 0.7× 147 1.7× 22 638
Vlahcevic Zr United States 10 260 0.8× 296 1.0× 83 0.4× 25 0.3× 67 0.8× 13 437

Countries citing papers authored by E Kok

Since Specialization
Citations

This map shows the geographic impact of E Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Kok more than expected).

Fields of papers citing papers by E Kok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Kok. The network helps show where E Kok may publish in the future.

Co-authorship network of co-authors of E Kok

This figure shows the co-authorship network connecting the top 25 collaborators of E Kok. A scholar is included among the top collaborators of E Kok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Kok. E Kok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekkers, Stijn, et al.. (2022). Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: A randomized controlled trial. Developmental Medicine & Child Neurology. 65(3). e27–e27. 1 indexed citations
2.
Polinder‐Bos, Harmke A., et al.. (2012). Severe hypertriglyceridaemia associated with the use of capecitabine.. PubMed. 70(2). 104–104. 8 indexed citations
3.
Kok, E, et al.. (1990). Metabolism of 3β-hydroxycholest-5-en-26-oic acid in hamsters. Cellular and Molecular Life Sciences. 46(3). 267–269. 2 indexed citations
4.
Kok, E & Norman B. Javitt. (1990). Cholesterol 26-hydroxylase activity of hamster liver mitochondria: isotope ratio analysis using deuterated 26-hydroxycholesterol.. Journal of Lipid Research. 31(4). 735–738. 6 indexed citations
5.
Javitt, Norman B., et al.. (1989). Bile Acid Synthesis in Cell Culture. Journal of Biological Chemistry. 264(18). 10384–10387. 37 indexed citations
6.
Kok, E, et al.. (1989). Cholic Acid Synthesis from 26-Hydroxycholesterol and 3-Hydroxy-5-cholestenoic Acid in the Rabbit. Journal of Biological Chemistry. 264(7). 3818–3821. 38 indexed citations
7.
Kok, E, et al.. (1988). Bile acid synthesis: down‐regulation by monohydroxy bile acids 1. The FASEB Journal. 2(2). 152–156. 31 indexed citations
8.
Javitt, Norman B., et al.. (1986). Bile acid synthesis. Metabolism of 3 beta-hydroxy-5-cholenoic acid to chenodeoxycholic acid.. Journal of Biological Chemistry. 261(27). 12486–12489. 24 indexed citations
9.
Kok, E, et al.. (1986). 26-Hydroxycholesterol disulfate: Metabolism and excretion in the normal neonate. Journal of Steroid Biochemistry. 25(6). 991–994. 2 indexed citations
10.
Krisans, Skaidrite K., et al.. (1985). Bile acid synthesis in rat liver peroxisomes: metabolism of 26-hydroxycholesterol to 3 beta-hydroxy-5-cholenoic acid. Journal of Lipid Research. 26(11). 1324–1332. 48 indexed citations
11.
Javitt, Norman B., et al.. (1984). NEONATAL CHOLESTASIS: IDENTIFICATION OF A METABOLIC ERROR IN BILE ACID SYNTHESIS. Pediatric Research. 18. 200A–200A. 7 indexed citations
12.
Javitt, Norman B., E Kok, Bertram I. Cohen, & Shlomo Burstein. (1984). Rapid synthesis of 26-hydroxycholesterol from mevalonic acid in the Syrian hamster. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 794(1). 172–174. 3 indexed citations
13.
Javitt, Norman B., et al.. (1982). Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol.. Journal of Lipid Research. 23(4). 627–630. 37 indexed citations
14.
Javitt, Norman B., et al.. (1982). Cholest-5-ene-3β,26-diol: Synthesis and biomedical use of a deuterated compound. Journal of Mass Spectrometry. 9(2). 61–63. 18 indexed citations
15.
Kok, E, et al.. (1981). Bile acid synthesis. Metabolism of 3 beta-hydroxy-5-cholenoic acid in the hamster.. Journal of Biological Chemistry. 256(12). 6155–6159. 21 indexed citations
16.
Javitt, Norman B., et al.. (1981). 26-Hydroxycholesterol. Identification and quantitation in human serum.. Journal of Biological Chemistry. 256(24). 12644–12646. 97 indexed citations
17.
Galeazzi, Renato L., E Kok, & Norman B. Javitt. (1976). Gas-liquid chromatography of bile acids: a new liquid phase for both acetate and trimethylsilyl derivatives. Journal of Lipid Research. 17(3). 288–290. 12 indexed citations
18.
Javitt, Norman B., Kevin P. Morrissey, Elliot R. Siegel, et al.. (1973). Cholestatic Syndromes in Infancy: Diagnostic Value of Serum Bile Acid Pattern and Cholestyramine Administration. Pediatric Research. 7(3). 119–125. 39 indexed citations
19.
Kaplowitz, Neil, E Kok, & Norman B. Javitt. (1973). Postprandial serum bile acid for the detection of hepatobiliary disease. Critical Care Medicine. 1(6). 338–338. 1 indexed citations
20.
Anderson, Karl E., E Kok, & Norman B. Javitt. (1972). Bile Acid Synthesis in Man: Metabolism of 7α-Hydroxycholesterol-14C and 26-Hydroxycholesterol-3H. Journal of Clinical Investigation. 51(1). 112–117. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026